Nutritional & Toxic Optic Neuropathies - Vision Villains
- 📌 Mnemonic: "TEAM Villains": Tobacco/Alcohol, Ethambutol, Amiodarone, Methanol, Vitamin deficiencies.
| Toxin/Deficiency | Key Features & Visual Field Defect | Management Highlights |
|---|---|---|
| Vit B12/Folate Def. | Painless, progressive bilateral ↓VA; dyschromatopsia. Centrocecal scotoma. | B12/Folate supplementation. |
| Ethambutol | Dose-dependent (>15 mg/kg/day); ↓VA, red-green dyschromatopsia. Centrocecal scotoma. | Discontinue drug; monitor. |
| Methanol | "Snowfield" vision, acidosis, CNS depression. Optic disc hyperemia → atrophy. Centrocecal scotoma. | Fomepizole/Ethanol, supportive, $HCO_3^-$. |
| Amiodarone | Insidious onset, bilateral disc swelling (NAION-like), often mild ↓VA. Various defects. | Discontinue if possible; monitor. |
⭐ Methanol poisoning classically causes optic disc hyperemia initially, followed by optic atrophy, and treatment involves fomepizole or ethanol.
Hereditary Optic Neuropathies - Gene-Sighted Woes
⭐ Leber Hereditary Optic Neuropathy (LHON) is characterized by maternal inheritance due to mitochondrial DNA mutations, typically affecting young males with acute/subacute painless bilateral vision loss.
- Leber Hereditary Optic Neuropathy (LHON)
- 📌 Mnemonic: Lads, Hereditary, Optic Neuropathy, Mothers (Maternal inheritance).
- Inheritance: Maternal (mtDNA mutations, e.g., 11778, 3460, 14484).
- Onset: 15-35 years, acute/subacute painless bilateral vision loss (sequential or simultaneous).
- Clinical: Central/cecocentral scotoma, ↓ color vision. Initially, peripapillary telangiectasia, disc hyperemia; later, optic atrophy.
- Associated: Cardiac arrhythmias (e.g., Wolff-Parkinson-White syndrome), skeletal abnormalities.
- Dominant Optic Atrophy (DOA) - Kjer type
- Inheritance: Autosomal Dominant (OPA1 gene mutation).
- Onset: Insidious, childhood (4-6 years).
- Clinical: Slowly progressive, bilateral, often asymmetric vision loss. Centrocecal scotoma, blue-yellow color defect (tritanopia). Temporal optic disc pallor.
| Feature | LHON | DOA (Kjer type) |
|---|---|---|
| Inheritance | Maternal (mtDNA) | Autosomal Dominant (OPA1) |
| Onset Age | 15-35 yrs (Acute) | 4-6 yrs (Insidious) |
| Vision Loss | Severe, bilateral, painless | Mild-moderate, progressive, bilateral |
| Fundus (Early) | Hyperemia, peripapillary telangiectasia | Normal or temporal pallor |
| Fundus (Late) | Optic atrophy | Optic atrophy (temporal > nasal) |
Compressive & Infiltrative Optic Neuropathies - Pressure Points
- Optic Nerve Glioma:
- Typically children, strong NF1 association.
- Painless proptosis, ↓ vision.
- MRI: Fusiform enlargement of optic nerve.
- Mgmt: Observation, chemotherapy if progressive.
- Optic Nerve Sheath Meningioma (ONSM):
- Primarily middle-aged women.
- MRI: "Tram-track" sign (calcification, enhancement around nerve).
- Mgmt: Observation, radiotherapy, surgery for severe cases.
⭐ Optic nerve sheath meningiomas classically present with the triad of painless progressive vision loss, optic atrophy, and optociliary shunt vessels (though shunt vessels are not always present).
- Thyroid Eye Disease (TED):
- Most common cause of unilateral/bilateral proptosis in adults.
- Diplopia, exposure keratopathy, compressive optic neuropathy.
- CT/MRI: Enlarged extraocular muscles (sparing tendons).
- Mgmt (optic neuropathy): IV methylprednisolone, orbital radiotherapy, surgical decompression.

- Infiltrative Optic Neuropathies (e.g., Sarcoidosis, Lymphoma):
- Sarcoidosis: Optic disc granuloma, uveitis, ↑ACE.
- Lymphoma: Older patients, often bilateral, masquerade syndrome.
- MRI: Optic nerve thickening, enhancement.
- Mgmt: Systemic steroids (sarcoidosis); chemotherapy/radiotherapy (lymphoma).
Traumatic Optic Neuropathy - Impact Insights
-
Classification:
- Direct TON: Penetrating injury, foreign body, direct nerve trauma.
- Indirect TON: More common; blunt head trauma (e.g., frontal impact). Forces transmitted to optic canal.
-
Pathophysiology (Indirect): Shearing forces on nerve fibers, vascular compromise (ischemia), edema within the unyielding optic canal.
-
Clinical Presentation: Acute, often severe, unilateral vision loss; Relative Afferent Pupillary Defect (RAPD) prominent; dyschromatopsia, visual field defects.
-
Immediate Assessment: Visual acuity, pupillary reactions, fundoscopy (may be normal initially), high-resolution CT scan (thin cuts of optic canal for fractures).

-
Management (Indirect TON): Highly controversial; evidence for any intervention is limited.
-
Options include observation, high-dose corticosteroids, or surgical optic nerve decompression. Decision is individualized.
⭐ The use of high-dose corticosteroids in indirect Traumatic Optic Neuropathy (TON) is controversial and not universally recommended; management decisions are often individualized based on presentation and timing.
High‑Yield Points - ⚡ Biggest Takeaways
- Nutritional/Toxic Optic Neuropathies: Cause bilateral, painless, progressive vision loss with central/cecocentral scotomas.
- Ethambutol toxicity: Dose-dependent, red-green dyschromatopsia.
- Methanol poisoning: Optic disc hyperemia then atrophy; formic acid is toxic.
- LHON: Mitochondrial inheritance, affects young males, acute severe bilateral vision loss.
- DOA: Autosomal dominant (OPA1), childhood onset, temporal pallor, blue-yellow color defect.
- Traumatic Optic Neuropathy: Indirect injury common, acute vision loss post-trauma.
- Amiodarone can cause insidious, bilateral optic neuropathy with prolonged disc swelling.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app